Item 9 Labs Corp. (INLB) Research

Based in the United States, Item 9 Labs Corp. operates as a comprehensive cannabis company, encompassing both vertical integration in cannabis operations and the franchising of dispensaries. The firm produces a wide spectrum of cannabis and related goods, such as raw flower, various concentrates, distillates, and necessary hardware. These cannabis and derived technologies and products are then supplied to consumers in Arizona via licensed retail dispensaries. Complementing its production activities, the company also develops and offers medical and adult-use cannabis dispensary franchises under its distinct Unity Rd brand. The main office for Item 9 Labs Corp. is found in Phoenix, Arizona.

Market snapshot

Symbol
INLB
Price
$0.00
Day change
0.00%
Market cap
$70.2K
P/E ratio
-0.00x
52-week range
0.0001-0.0001
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Next earnings
in 2 months

Peer companies

  • Biome Grow Inc. (BIOIF)
  • Cannabis Global, Inc. (CBGL)
  • Green Rain Energy Holdings Inc. (GREH)
  • Hero Technologies Inc. (HENC)
  • Isodiol International Inc. (ISOLF)
  • Jack Nathan Medical Corp. (JNHMF)
  • Lords & Company Worldwide Holdings Inc. (LRDSF)
  • South American Gold Corp. (SAGD)

Recent insider activity

  • Kutscher Eric — trade (0 shares) on 2021-12-14
  • Taylor Lawrence X. III — trade (0 shares) on 2021-12-14
  • Bowden Douglas P — trade (0 shares) on 2020-02-04
  • Bowden Douglas P — trade (0 shares) on 2020-02-04
  • Bowden Douglas P — trade (1100000 shares) on 2020-03-23

Open Item 9 Labs Corp. (INLB) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.